Dr. Lucas Przymusinski is a physician and partner in DLA Piper's Product Liability and Mass Tort group, recognized by Law360 as the 2013 Product Liability Group of the Year. He focuses his practice on drug and device litigation, mass torts, toxic torts, class actions and product liability.

Dr. Przymusinski has served on numerous national counsel teams in mass tort litigation. He has extensive experience in defending pharmaceutical product liability actions and has been involved in every stage of litigation, including strategic assessment and planning, motion practice, expert development, trial and appellate practice.

Dr. Przymusinski also regularly counsels clients on a wide range of issues, including risk management, product labeling, marketing and regulatory, and First Amendment free speech rights. Among his areas of interest are federal preemption, medical causation and appellate practice.